Advances in Hematological Malignancies
Recent decades have witnessed remarkable advancements in the domain of here hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and gene editing are altering the outlook for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering hope for more successful treatment opt